RxTeach
  • Home
  • Clinical Pharmacy
  • Journal Clubs
  • Pharmacy Industry
  • Health & Wellness
  • Students
  • Donations
  • About
  • Day in the Life
  • Science
  • Connect with us!
Sign in Subscribe
Clinical Pharmacy

The OPAL Trial

Today we will walk through a brief journal club on a recent publication in The Lancet in June 2023.

  • Kristen Lindauer, PharmD, BCPS, AAHIVP

Kristen Lindauer, PharmD, BCPS, AAHIVP

13 Sep 2023 • 6 min read
Share
The OPAL Trial
Photo by Ioana Cristiana / Unsplash

This post is for subscribers only

Subscribe now

Already have an account? Sign in

Centanafadine: A Revolution in ADHD Treatment?

Centanafadine: A Revolution in ADHD Treatment?

Centanafadine (Simtriyo), a first-in-class NDSRI for ADHD, offers a new treatment approach but carries important safety and abuse warnings.
10 Sep 2026 5 min read
The PM Problem: Is Diphenhydramine Actually Good for Sleep?
Members only

The PM Problem: Is Diphenhydramine Actually Good for Sleep?

09 Sep 2026 6 min read
GI Malignancies: Pancreatic Cancer

GI Malignancies: Pancreatic Cancer

Despite representing only a small percentage of all cancers, it is a leading cause of cancer-related mortality due to its aggressive biology, delayed diagnosis, and resistance to many traditional therapeutic approaches.
02 Sep 2026 5 min read
RxTeach © 2026
Powered by Ghost